首页> 外国专利> HEPARIN DEGRADATION VIA ASCORBIC ACID, CUPRIC ACETATE AND HYDROGEN PEROXIDE

HEPARIN DEGRADATION VIA ASCORBIC ACID, CUPRIC ACETATE AND HYDROGEN PEROXIDE

机译:通过抗坏血酸,乙酸铜和过氧化氢降解肝素

摘要

Process for the preparation of oligosaccharides and oligosaccharide fractions by degradation of heparin, which comprises submitting to incubation an aqueous solution of heparin containing from 5 to 30 g of heparin/liter in the presence of 4-50 m.moles/l of cupric acetate and 50-300 m.moles/l of hydrogen peroxide, at a temperature of 40 DEG -50 DEG C., for 20-24 hours and keeping the pH at a value of 7.8 by means of sodium acetate. The obtained products show a high inhibiting property of the Xa factor, a high antithrombotic activity and a very modest anticoagulant activity; therefore they are very interesting for a possible utilization as drugs in the antithrombotic treatment, practically free from any risk of haemorrhages.
机译:通过降解肝素制备寡糖和寡糖馏分的方法,该方法包括在4-50 mol.mol / l乙酸铜和1%醋酸铜存在下,将含有5至30 g肝素/升的肝素水溶液进行温育。在40℃-50℃的温度下,将50-300毫摩尔/升的过氧化氢保持20-24小时,并用乙酸钠将pH值保持在7.8。所获得的产物显示出对Xa因子的高抑制性质,高抗血栓形成活性和非常适度的抗凝活性。因此,它们对于作为抗血栓治疗药物的可能用途非常有趣,几乎没有出血的风险。

著录项

  • 公开/公告号AU2509384A

    专利类型

  • 公开/公告日1984-09-13

    原文格式PDF

  • 申请/专利权人 OPOCRIN S.P.A.;

    申请/专利号AU19840025093

  • 发明设计人 PIETRO BIANCHINI;

    申请日1984-02-27

  • 分类号C08B37/10;

  • 国家 AU

  • 入库时间 2022-08-22 09:02:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号